0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and United States Levodopa Market Insights, Forecast to 2027
Published Date: November 2021
|
Report Code: QYRE-Auto-15B7475
Home | Market Reports | Health | Health Conditions | Neurological Conditions
Global and United States Levodopa Market Insights Forecast to 2027

Global and United States Levodopa Market Insights, Forecast to 2027

Code: QYRE-Auto-15B7475
Report
November 2021
156 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Levodopa is one of the main drugs used to treat Parkinson's symptoms. It can be used at all stages of the condition. The statistic scope is Levodopa API in this report.
Market Analysis and Insights: Global and United States Levodopa Market
This report focuses on global and United States Levodopa market.
In 2020, the global Levodopa market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In United States the Levodopa market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Levodopa Scope and Market Size
Levodopa market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Levodopa market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For United States market, this report focuses on the Levodopa market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.

Segment by Type

Purity: 98%
Purity: 99%

Segment by Application

Tablet Products
Capsule Products
Others

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

BY COMPANY

Shandong Xinhua Pharmaceutical Co
Ajinomoto
Daiichi Sankyo Chemical Pharma Co
Delmar Chemicals Inc
Divis Laboratories Ltd
Egis Pharmaceuticals Private Ltd
Hangzhou Longshine Bio-Tech Co
Hoffmann La Roche Inc
Suzhou Ryway Biotech
Teva Pharmaceutical Industries Ltd
Torrent Pharmaceuticals Limited
Zhejiang Huahai Pharmaceutical Co
Zhejiang Wild Wind Pharmaceutical
Broahony Group
Lanpharma Chemical Co
1 Study Coverage
1.1 Levodopa Product Introduction
1.2 Market by Type
1.2.1 Global Levodopa Market Size Growth Rate by Type
1.2.2 Purity: 98%
1.2.3 Purity: 99%
1.3 Market by Application
1.3.1 Global Levodopa Market Size Growth Rate by Application
1.3.2 Tablet Products
1.3.3 Capsule Products
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Levodopa Market Size, Estimates and Forecasts
2.1.1 Global Levodopa Revenue 2016-2027
2.1.2 Global Levodopa Sales 2016-2027
2.2 Global Levodopa, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Levodopa Historical Market Size by Region (2016-2021)
2.3.1 Global Levodopa Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Levodopa Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Levodopa Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Levodopa Sales Forecast by Region (2022-2027)
2.4.2 Global Levodopa Revenue Forecast by Region (2022-2027)
3 Global Levodopa Competitor Landscape by Players
3.1 Global Top Levodopa Manufacturers by Sales
3.1.1 Global Levodopa Sales by Manufacturer (2016-2021)
3.1.2 Global Levodopa Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Levodopa Manufacturers by Revenue
3.2.1 Key Levodopa Manufacturers Covered: Ranking by Revenue
3.2.2 Global Levodopa Revenue by Manufacturers (2016-2021)
3.2.3 Global Levodopa Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Levodopa Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Levodopa Revenue in 2020
3.2.6 Global Levodopa Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Levodopa Price by Manufacturers
3.4 Global Levodopa Manufacturing Base Distribution, Product Types
3.4.1 Levodopa Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Levodopa Product Type
3.4.3 Date of International Manufacturers Enter into Levodopa Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Levodopa Market Size by Type (2016-2021)
4.1.1 Global Levodopa Sales by Type (2016-2021)
4.1.2 Global Levodopa Revenue by Type (2016-2021)
4.1.3 Levodopa Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Levodopa Market Size Forecast by Type (2022-2027)
4.2.1 Global Levodopa Sales Forecast by Type (2022-2027)
4.2.2 Global Levodopa Revenue Forecast by Type (2022-2027)
4.2.3 Levodopa Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Levodopa Market Size by Application (2016-2021)
5.1.1 Global Levodopa Sales by Application (2016-2021)
5.1.2 Global Levodopa Revenue by Application (2016-2021)
5.1.3 Levodopa Price by Application (2016-2021)
5.2 Levodopa Market Size Forecast by Application (2022-2027)
5.2.1 Global Levodopa Sales Forecast by Application (2022-2027)
5.2.2 Global Levodopa Revenue Forecast by Application (2022-2027)
5.2.3 Global Levodopa Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Levodopa Market Size YoY Growth 2016-2027
6.1.1 United States Levodopa Sales YoY Growth 2016-2027
6.1.2 United States Levodopa Revenue YoY Growth 2016-2027
6.1.3 United States Levodopa Market Share in Global Market 2016-2027
6.2 United States Levodopa Market Size by Players (International and Local Players)
6.2.1 United States Top Levodopa Players by Sales (2016-2021)
6.2.2 United States Top Levodopa Players by Revenue (2016-2021)
6.3 United States Levodopa Historic Market Review by Type (2016-2021)
6.3.1 United States Levodopa Sales Market Share by Type (2016-2021)
6.3.2 United States Levodopa Revenue Market Share by Type (2016-2021)
6.3.3 United States Levodopa Price by Type (2016-2021)
6.4 United States Levodopa Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Levodopa Sales Forecast by Type (2022-2027)
6.4.2 United States Levodopa Revenue Forecast by Type (2022-2027)
6.4.3 United States Levodopa Price Forecast by Type (2022-2027)
6.5 United States Levodopa Historic Market Review by Application (2016-2021)
6.5.1 United States Levodopa Sales Market Share by Application (2016-2021)
6.5.2 United States Levodopa Revenue Market Share by Application (2016-2021)
6.5.3 United States Levodopa Price by Application (2016-2021)
6.6 United States Levodopa Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Levodopa Sales Forecast by Application (2022-2027)
6.6.2 United States Levodopa Revenue Forecast by Application (2022-2027)
6.6.3 United States Levodopa Price Forecast by Application (2022-2027)
7 North America
7.1 North America Levodopa Market Size YoY Growth 2016-2027
7.2 North America Levodopa Market Facts & Figures by Country
7.2.1 North America Levodopa Sales by Country (2016-2021)
7.2.2 North America Levodopa Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Levodopa Market Size YoY Growth 2016-2027
8.2 Asia Pacific Levodopa Market Facts & Figures by Region
8.2.1 Asia Pacific Levodopa Sales by Region (2016-2021)
8.2.2 Asia Pacific Levodopa Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Levodopa Market Size YoY Growth 2016-2027
9.2 Europe Levodopa Market Facts & Figures by Country
9.2.1 Europe Levodopa Sales by Country (2016-2021)
9.2.2 Europe Levodopa Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Levodopa Market Size YoY Growth 2016-2027
10.2 Latin America Levodopa Market Facts & Figures by Country
10.2.1 Latin America Levodopa Sales by Country (2016-2021)
10.2.2 Latin America Levodopa Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Levodopa Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Levodopa Market Facts & Figures by Country
11.2.1 Middle East and Africa Levodopa Sales by Country (2016-2021)
11.2.2 Middle East and Africa Levodopa Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Shandong Xinhua Pharmaceutical Co
12.1.1 Shandong Xinhua Pharmaceutical Co Corporation Information
12.1.2 Shandong Xinhua Pharmaceutical Co Description and Business Overview
12.1.3 Shandong Xinhua Pharmaceutical Co Levodopa Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Shandong Xinhua Pharmaceutical Co Levodopa Products Offered
12.1.5 Shandong Xinhua Pharmaceutical Co Recent Development
12.2 Ajinomoto
12.2.1 Ajinomoto Corporation Information
12.2.2 Ajinomoto Description and Business Overview
12.2.3 Ajinomoto Levodopa Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Ajinomoto Levodopa Products Offered
12.2.5 Ajinomoto Recent Development
12.3 Daiichi Sankyo Chemical Pharma Co
12.3.1 Daiichi Sankyo Chemical Pharma Co Corporation Information
12.3.2 Daiichi Sankyo Chemical Pharma Co Description and Business Overview
12.3.3 Daiichi Sankyo Chemical Pharma Co Levodopa Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Daiichi Sankyo Chemical Pharma Co Levodopa Products Offered
12.3.5 Daiichi Sankyo Chemical Pharma Co Recent Development
12.4 Delmar Chemicals Inc
12.4.1 Delmar Chemicals Inc Corporation Information
12.4.2 Delmar Chemicals Inc Description and Business Overview
12.4.3 Delmar Chemicals Inc Levodopa Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Delmar Chemicals Inc Levodopa Products Offered
12.4.5 Delmar Chemicals Inc Recent Development
12.5 Divis Laboratories Ltd
12.5.1 Divis Laboratories Ltd Corporation Information
12.5.2 Divis Laboratories Ltd Description and Business Overview
12.5.3 Divis Laboratories Ltd Levodopa Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Divis Laboratories Ltd Levodopa Products Offered
12.5.5 Divis Laboratories Ltd Recent Development
12.6 Egis Pharmaceuticals Private Ltd
12.6.1 Egis Pharmaceuticals Private Ltd Corporation Information
12.6.2 Egis Pharmaceuticals Private Ltd Description and Business Overview
12.6.3 Egis Pharmaceuticals Private Ltd Levodopa Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Egis Pharmaceuticals Private Ltd Levodopa Products Offered
12.6.5 Egis Pharmaceuticals Private Ltd Recent Development
12.7 Hangzhou Longshine Bio-Tech Co
12.7.1 Hangzhou Longshine Bio-Tech Co Corporation Information
12.7.2 Hangzhou Longshine Bio-Tech Co Description and Business Overview
12.7.3 Hangzhou Longshine Bio-Tech Co Levodopa Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Hangzhou Longshine Bio-Tech Co Levodopa Products Offered
12.7.5 Hangzhou Longshine Bio-Tech Co Recent Development
12.8 Hoffmann La Roche Inc
12.8.1 Hoffmann La Roche Inc Corporation Information
12.8.2 Hoffmann La Roche Inc Description and Business Overview
12.8.3 Hoffmann La Roche Inc Levodopa Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Hoffmann La Roche Inc Levodopa Products Offered
12.8.5 Hoffmann La Roche Inc Recent Development
12.9 Suzhou Ryway Biotech
12.9.1 Suzhou Ryway Biotech Corporation Information
12.9.2 Suzhou Ryway Biotech Description and Business Overview
12.9.3 Suzhou Ryway Biotech Levodopa Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Suzhou Ryway Biotech Levodopa Products Offered
12.9.5 Suzhou Ryway Biotech Recent Development
12.10 Teva Pharmaceutical Industries Ltd
12.10.1 Teva Pharmaceutical Industries Ltd Corporation Information
12.10.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
12.10.3 Teva Pharmaceutical Industries Ltd Levodopa Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Teva Pharmaceutical Industries Ltd Levodopa Products Offered
12.10.5 Teva Pharmaceutical Industries Ltd Recent Development
12.11 Shandong Xinhua Pharmaceutical Co
12.11.1 Shandong Xinhua Pharmaceutical Co Corporation Information
12.11.2 Shandong Xinhua Pharmaceutical Co Description and Business Overview
12.11.3 Shandong Xinhua Pharmaceutical Co Levodopa Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Shandong Xinhua Pharmaceutical Co Levodopa Products Offered
12.11.5 Shandong Xinhua Pharmaceutical Co Recent Development
12.12 Zhejiang Huahai Pharmaceutical Co
12.12.1 Zhejiang Huahai Pharmaceutical Co Corporation Information
12.12.2 Zhejiang Huahai Pharmaceutical Co Description and Business Overview
12.12.3 Zhejiang Huahai Pharmaceutical Co Levodopa Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Zhejiang Huahai Pharmaceutical Co Products Offered
12.12.5 Zhejiang Huahai Pharmaceutical Co Recent Development
12.13 Zhejiang Wild Wind Pharmaceutical
12.13.1 Zhejiang Wild Wind Pharmaceutical Corporation Information
12.13.2 Zhejiang Wild Wind Pharmaceutical Description and Business Overview
12.13.3 Zhejiang Wild Wind Pharmaceutical Levodopa Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Zhejiang Wild Wind Pharmaceutical Products Offered
12.13.5 Zhejiang Wild Wind Pharmaceutical Recent Development
12.14 Broahony Group
12.14.1 Broahony Group Corporation Information
12.14.2 Broahony Group Description and Business Overview
12.14.3 Broahony Group Levodopa Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Broahony Group Products Offered
12.14.5 Broahony Group Recent Development
12.15 Lanpharma Chemical Co
12.15.1 Lanpharma Chemical Co Corporation Information
12.15.2 Lanpharma Chemical Co Description and Business Overview
12.15.3 Lanpharma Chemical Co Levodopa Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Lanpharma Chemical Co Products Offered
12.15.5 Lanpharma Chemical Co Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Levodopa Industry Trends
13.2 Levodopa Market Drivers
13.3 Levodopa Market Challenges
13.4 Levodopa Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Levodopa Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
    Table 1. Global Levodopa Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
    Table 2. Major Manufacturers of Purity: 98%
    Table 3. Major Manufacturers of Purity: 99%
    Table 4. Global Levodopa Market Size Growth Rate by Application (2021-2027) & (MT)
    Table 5. Global Levodopa Market Size by Region (MT) & (US$ Million), 2016 VS 2021 VS 2027
    Table 6. Global Levodopa Sales by Regions (2016-2021) & (MT)
    Table 7. Global Levodopa Sales Market Share by Regions (2016-2021)
    Table 8. Global Levodopa Revenue by Regions (2016-2021) & (US$ Million)
    Table 9. Global Levodopa Sales Forecast by Region (2022-2027) & (MT)
    Table 10. Global Levodopa Sales Market Share Forecast by Region (2022-2027)
    Table 11. Global Levodopa Revenue Forecast by Region (2022-2027) & (US$ Million)
    Table 12. Global Levodopa Revenue Market Share Forecast by Region (2022-2027)
    Table 13. Global Levodopa Sales by Manufacturers (2016-2021) (MT)
    Table 14. Global Levodopa Sales Share by Manufacturers (2016-2021)
    Table 15. Ranking of Global Top Levodopa Manufacturers by Revenue (US$ Million) in 2020
    Table 16. Levodopa Revenue by Manufacturers (2016-2021) (US$ Million)
    Table 17. Levodopa Revenue Share by Manufacturers (2016-2021)
    Table 18. Global Levodopa Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
    Table 19. Global Levodopa by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Levodopa as of 2020)
    Table 20. Key Manufacturers Levodopa Price (2016-2021) (USD/MT)
    Table 21. Levodopa Manufacturers Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Levodopa Product Type
    Table 23. Date of International Manufacturers Enter into Levodopa Market
    Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 25. Global Levodopa Sales by Type (2016-2021) (MT)
    Table 26. Global Levodopa Sales Share by Type (2016-2021)
    Table 27. Global Levodopa Revenue by Type (2016-2021) (US$ Million)
    Table 28. Global Levodopa Revenue Share by Type (2016-2021)
    Table 29. Levodopa Average Selling Price (ASP) by Type (2016-2021) & (USD/MT)
    Table 30. Global Levodopa Sales Forecast by Type (2022-2027) & (MT)
    Table 31. Global Levodopa Sales Market Share Forecast by Type (2022-2027)
    Table 32. Global Levodopa Revenue Forecast V (2022-2027) & (US$ Million)
    Table 33. Global Levodopa Revenue Market Share Forecast by Type (2022-2027)
    Table 34. Global Levodopa Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/MT)
    Table 35. Global Levodopa Sales by Application (2016-2021) (MT)
    Table 36. Global Levodopa Sales Share by Application (2016-2021)
    Table 37. Global Levodopa Revenue by Application (2016-2021) (US$ Million)
    Table 38. Global Levodopa Revenue Share by Application (2016-2021)
    Table 39. Levodopa Average Selling Price (ASP) by Application (2016-2021) & (USD/MT)
    Table 40. Global Levodopa Sales Forecast by Application (2022-2027) & (MT)
    Table 41. Global Levodopa Sales Market Share Forecast by Application (2022-2027)
    Table 42. Global Levodopa Revenue Forecast by Application (2022-2027) & (US$ Million)
    Table 43. Global Levodopa Revenue Market Share Forecast by Application (2022-2027)
    Table 44. Global Levodopa Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/MT)
    Table 45. United States Levodopa Sales (MT) of Key Companies (2016-2021)
    Table 46. United States Levodopa Sales Share by Company (2016-2021)
    Table 47. United States Levodopa Revenue (US$ Million) by Company (2016-2021)
    Table 48. United States Levodopa Revenue Share by Company (2016-2021)
    Table 49. United States Levodopa Sales (MT) by Type (2016-2021)
    Table 50. United States Levodopa Sales Share by Type (2016-2021)
    Table 51. United States Levodopa Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 52. United States Levodopa Price (USD/MT) by Type (2016-2021)
    Table 53. United States Levodopa Sales (MT) by Type (2022-2027)
    Table 54. United States Levodopa Sales Share by Type (2022-2027)
    Table 55. United States Levodopa Revenue (US$ Million) Market Share by Type (2022-2027)
    Table 56. United States Levodopa Revenue Share by Type (2022-2027)
    Table 57. United States Levodopa Price (USD/MT) by Type (2022-2027)
    Table 58. United States Levodopa Sales (MT) by Application (2016-2021)
    Table 59. United States Levodopa Sales Share by Application (2016-2021)
    Table 60. United States Levodopa Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 61. United States Levodopa Price (USD/MT) by Application (2016-2021)
    Table 62. United States Levodopa Sales (MT) by Application (2022-2027)
    Table 63. United States Levodopa Sales Share by Application (2022-2027)
    Table 64. United States Levodopa Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 65. United States Levodopa Revenue Share by Application (2022-2027)
    Table 66. United States Levodopa Price (USD/MT) by Application (2022-2027)
    Table 67. North America Levodopa Sales by Country (2016-2021) & (MT)
    Table 68. North America Levodopa Sales Market Share by Country (2016-2021)
    Table 69. North America Levodopa Revenue by Country (2016-2021) & (US$ Million)
    Table 70. North America Levodopa Revenue Market Share by Country (2016-2021)
    Table 71. Asia Pacific Levodopa Sales by Region (2016-2021) & (MT)
    Table 72. Asia Pacific Levodopa Sales Market Share by Region (2016-2021)
    Table 73. Asia Pacific Levodopa Revenue by Region (2016-2021) & (US$ Million)
    Table 74. Asia Pacific Levodopa Revenue Market Share by Region (2016-2021)
    Table 75. Europe Levodopa Sales by Country (2016-2021) & (MT)
    Table 76. Europe Levodopa Sales Market Share by Country (2016-2021)
    Table 77. Europe Levodopa Revenue by Country (2016-2021) & (US$ Million)
    Table 78. Europe Levodopa Revenue Market Share by Country (2016-2021)
    Table 79. Latin America Levodopa Sales by Country (2016-2021) & (MT)
    Table 80. Latin America Levodopa Sales Market Share by Country (2016-2021)
    Table 81. Latin Americaa Levodopa Revenue by Country (2016-2021) & (US$ Million)
    Table 82. Latin America Levodopa Revenue Market Share by Country (2016-2021)
    Table 83. Middle East and Africa Levodopa Sales by Country (2016-2021) & (MT)
    Table 84. Middle East and Africa Levodopa Sales Market Share by Country (2016-2021)
    Table 85. Middle East and Africa Levodopa Revenue by Country (2016-2021) & (US$ Million)
    Table 86. Middle East and Africa Levodopa Revenue Market Share by Country (2016-2021)
    Table 87. Shandong Xinhua Pharmaceutical Co Corporation Information
    Table 88. Shandong Xinhua Pharmaceutical Co Description and Business Overview
    Table 89. Shandong Xinhua Pharmaceutical Co Levodopa Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 90. Shandong Xinhua Pharmaceutical Co Levodopa Product
    Table 91. Shandong Xinhua Pharmaceutical Co Recent Development
    Table 92. Ajinomoto Corporation Information
    Table 93. Ajinomoto Description and Business Overview
    Table 94. Ajinomoto Levodopa Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 95. Ajinomoto Product
    Table 96. Ajinomoto Recent Development
    Table 97. Daiichi Sankyo Chemical Pharma Co Corporation Information
    Table 98. Daiichi Sankyo Chemical Pharma Co Description and Business Overview
    Table 99. Daiichi Sankyo Chemical Pharma Co Levodopa Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 100. Daiichi Sankyo Chemical Pharma Co Product
    Table 101. Daiichi Sankyo Chemical Pharma Co Recent Development
    Table 102. Delmar Chemicals Inc Corporation Information
    Table 103. Delmar Chemicals Inc Description and Business Overview
    Table 104. Delmar Chemicals Inc Levodopa Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 105. Delmar Chemicals Inc Product
    Table 106. Delmar Chemicals Inc Recent Development
    Table 107. Divis Laboratories Ltd Corporation Information
    Table 108. Divis Laboratories Ltd Description and Business Overview
    Table 109. Divis Laboratories Ltd Levodopa Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 110. Divis Laboratories Ltd Product
    Table 111. Divis Laboratories Ltd Recent Development
    Table 112. Egis Pharmaceuticals Private Ltd Corporation Information
    Table 113. Egis Pharmaceuticals Private Ltd Description and Business Overview
    Table 114. Egis Pharmaceuticals Private Ltd Levodopa Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 115. Egis Pharmaceuticals Private Ltd Product
    Table 116. Egis Pharmaceuticals Private Ltd Recent Development
    Table 117. Hangzhou Longshine Bio-Tech Co Corporation Information
    Table 118. Hangzhou Longshine Bio-Tech Co Description and Business Overview
    Table 119. Hangzhou Longshine Bio-Tech Co Levodopa Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 120. Hangzhou Longshine Bio-Tech Co Product
    Table 121. Hangzhou Longshine Bio-Tech Co Recent Development
    Table 122. Hoffmann La Roche Inc Corporation Information
    Table 123. Hoffmann La Roche Inc Description and Business Overview
    Table 124. Hoffmann La Roche Inc Levodopa Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 125. Hoffmann La Roche Inc Product
    Table 126. Hoffmann La Roche Inc Recent Development
    Table 127. Suzhou Ryway Biotech Corporation Information
    Table 128. Suzhou Ryway Biotech Description and Business Overview
    Table 129. Suzhou Ryway Biotech Levodopa Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 130. Suzhou Ryway Biotech Product
    Table 131. Suzhou Ryway Biotech Recent Development
    Table 132. Teva Pharmaceutical Industries Ltd Corporation Information
    Table 133. Teva Pharmaceutical Industries Ltd Description and Business Overview
    Table 134. Teva Pharmaceutical Industries Ltd Levodopa Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 135. Teva Pharmaceutical Industries Ltd Product
    Table 136. Teva Pharmaceutical Industries Ltd Recent Development
    Table 137. Torrent Pharmaceuticals Limited Corporation Information
    Table 138. Torrent Pharmaceuticals Limited Description and Business Overview
    Table 139. Torrent Pharmaceuticals Limited Levodopa Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 140. Torrent Pharmaceuticals Limited Product
    Table 141. Torrent Pharmaceuticals Limited Recent Development
    Table 142. Zhejiang Huahai Pharmaceutical Co Corporation Information
    Table 143. Zhejiang Huahai Pharmaceutical Co Description and Business Overview
    Table 144. Zhejiang Huahai Pharmaceutical Co Levodopa Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 145. Zhejiang Huahai Pharmaceutical Co Product
    Table 146. Zhejiang Huahai Pharmaceutical Co Recent Development
    Table 147. Zhejiang Wild Wind Pharmaceutical Corporation Information
    Table 148. Zhejiang Wild Wind Pharmaceutical Description and Business Overview
    Table 149. Zhejiang Wild Wind Pharmaceutical Levodopa Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 150. Zhejiang Wild Wind Pharmaceutical Product
    Table 151. Zhejiang Wild Wind Pharmaceutical Recent Development
    Table 152. Broahony Group Corporation Information
    Table 153. Broahony Group Description and Business Overview
    Table 154. Broahony Group Levodopa Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 155. Broahony Group Product
    Table 156. Broahony Group Recent Development
    Table 157. Lanpharma Chemical Co Corporation Information
    Table 158. Lanpharma Chemical Co Description and Business Overview
    Table 159. Lanpharma Chemical Co Levodopa Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2016-2021)
    Table 160. Lanpharma Chemical Co Product
    Table 161. Lanpharma Chemical Co Recent Development
    Table 162. Levodopa Market Trends
    Table 163. Levodopa Market Drivers
    Table 164. Levodopa Market Challenges
    Table 165. Levodopa Market Restraints
    Table 166. Levodopa Customers List
    Table 167. Levodopa Distributors List
    Table 168. Research Programs/Design for This Report
    Table 169. Key Data Information from Secondary Sources
    Table 170. Key Data Information from Primary Sources
List of Figures
    Figure 1. Levodopa Product Picture
    Figure 2. Global Levodopa Sales Market Share by Type in 2020 & 2027
    Figure 3. Purity: 98% Product Picture
    Figure 4. Purity: 99% Product Picture
    Figure 5. Global Levodopa Sales Market Share by Application in 2020 & 2027
    Figure 6. Tablet Products
    Figure 7. Capsule Products
    Figure 8. Others
    Figure 9. Levodopa Report Years Considered
    Figure 10. Global Levodopa Market Size, (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Levodopa Market Size 2016-2027 (US$ Million)
    Figure 12. Global Levodopa Sales 2016-2027 (MT)
    Figure 13. Global Levodopa Market Size Market Share by Region: 2021 Versus 2027
    Figure 14. Global Levodopa Sales Market Share by Region (2016-2021)
    Figure 15. Global Levodopa Sales Market Share by Region in 2020
    Figure 16. Global Levodopa Revenue Market Share by Region (2016-2021)
    Figure 17. Global Levodopa Revenue Market Share by Region in 2020
    Figure 18. Global Levodopa Sales Share by Manufacturer in 2020
    Figure 19. The Top 10 and 5 Players Market Share by Levodopa Revenue in 2020
    Figure 20. Levodopa Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 21. Global Levodopa Sales Market Share by Type (2016-2021)
    Figure 22. Global Levodopa Sales Market Share by Type in 2020
    Figure 23. Global Levodopa Revenue Market Share by Type (2016-2021)
    Figure 24. Global Levodopa Revenue Market Share by Type in 2020
    Figure 25. Global Levodopa Sales Market Share by Application (2016-2021)
    Figure 26. Global Levodopa Sales Market Share by Application in 2020
    Figure 27. Global Levodopa Revenue Market Share by Application (2016-2021)
    Figure 28. Global Levodopa Revenue Market Share by Application in 2020
    Figure 29. United States Levodopa Sales Growth Rate 2016-2027 (MT)
    Figure 30. United States Levodopa Revenue Growth Rate 2016-2027 (US$ Million)
    Figure 31. United States Levodopa Market Share in Global Market 2016-2027
    Figure 32. United States 5 and 10 Largest Levodopa Players Market Share by Revenue in Levodopa in 2020
    Figure 33. United States Levodopa Revenue Share by Type (2016-2021)
    Figure 34. United States Levodopa Revenue Growth Rate by Type in 2016 & 2020
    Figure 35. United States Levodopa Revenue Share by Application (2016-2021)
    Figure 36. United States Levodopa Revenue Growth Rate by Application in 2016 & 2020
    Figure 37. North America Levodopa Sales Growth Rate 2016-2021 (MT)
    Figure 38. North America Levodopa Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 39. North America Levodopa Sales Market Share by Country in 2020
    Figure 40. North America Levodopa Revenue Market Share by Country in 2020
    Figure 41. U.S. Levodopa Sales Growth Rate (2016-2021) (MT)
    Figure 42. U.S. Levodopa Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 43. Canada Levodopa Sales Growth Rate (2016-2021) (MT)
    Figure 44. Canada Levodopa Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 45. Europe Levodopa Sales Growth Rate 2016-2021 (MT)
    Figure 46. Europe Levodopa Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 47. Europe Levodopa Sales Market Share by Country in 2020
    Figure 48. Europe Levodopa Revenue Market Share by Country in 2020
    Figure 49. Germany Levodopa Sales Growth Rate (2016-2021) (MT)
    Figure 50. Germany Levodopa Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 51. France Levodopa Sales Growth Rate (2016-2021) (MT)
    Figure 52. France Levodopa Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 53. U.K. Levodopa Sales Growth Rate (2016-2021) (MT)
    Figure 54. U.K. Levodopa Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 55. Italy Levodopa Sales Growth Rate (2016-2021) (MT)
    Figure 56. Italy Levodopa Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 57. Russia Levodopa Sales Growth Rate (2016-2021) (MT)
    Figure 58. Russia Levodopa Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 59. Asia Pacific Levodopa Sales Growth Rate 2016-2021 (MT)
    Figure 60. Asia Pacific Levodopa Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 61. Asia Pacific Levodopa Sales Market Share by Region in 2020
    Figure 62. Asia Pacific Levodopa Revenue Market Share by Region in 2020
    Figure 63. China Levodopa Sales Growth Rate (2016-2021) (MT)
    Figure 64. China Levodopa Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 65. Japan Levodopa Sales Growth Rate (2016-2021) (MT)
    Figure 66. Japan Levodopa Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 67. South Korea Levodopa Sales Growth Rate (2016-2021) (MT)
    Figure 68. South Korea Levodopa Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 69. India Levodopa Sales Growth Rate (2016-2021) (MT)
    Figure 70. India Levodopa Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 71. Australia Levodopa Sales Growth Rate (2016-2021) (MT)
    Figure 72. Australia Levodopa Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 73. Taiwan Levodopa Sales Growth Rate (2016-2021) (MT)
    Figure 74. Taiwan Levodopa Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 75. Indonesia Levodopa Sales Growth Rate (2016-2021) (MT)
    Figure 76. Indonesia Levodopa Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 77. Thailand Levodopa Sales Growth Rate (2016-2021) (MT)
    Figure 78. Thailand Levodopa Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 79. Malaysia Levodopa Sales Growth Rate (2016-2021) (MT)
    Figure 80. Malaysia Levodopa Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 81. Philippines Levodopa Sales Growth Rate (2016-2021) (MT)
    Figure 82. Philippines Levodopa Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 83. Vietnam Levodopa Sales Growth Rate (2016-2021) (MT)
    Figure 84. Vietnam Levodopa Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 85. Latin America Levodopa Sales Growth Rate 2016-2021 (MT)
    Figure 86. Latin America Levodopa Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 87. Latin America Levodopa Sales Market Share by Country in 2020
    Figure 88. Latin America Levodopa Revenue Market Share by Country in 2020
    Figure 89. Mexico Levodopa Sales Growth Rate (2016-2021) (MT)
    Figure 90. Mexico Levodopa Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 91. Brazil Levodopa Sales Growth Rate (2016-2021) (MT)
    Figure 92. Brazil Levodopa Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 93. Argentina Levodopa Sales Growth Rate (2016-2021) (MT)
    Figure 94. Argentina Levodopa Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 95. Middle East and Africa Levodopa Sales Growth Rate 2016-2021 (MT)
    Figure 96. Middle East and Africa Levodopa Revenue Growth Rate 2016-2021 (US$ Million)
    Figure 97. Middle East and Africa Levodopa Sales Market Share by Country in 2020
    Figure 98. Middle East and Africa Levodopa Revenue Market Share by Country in 2020
    Figure 99. Turkey Levodopa Sales Growth Rate (2016-2021) (MT)
    Figure 100. Turkey Levodopa Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 101. Saudi Arabia Levodopa Sales Growth Rate (2016-2021) (MT)
    Figure 102. Saudi Arabia Levodopa Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 103. U.A.E Levodopa Sales Growth Rate (2016-2021) (MT)
    Figure 104. U.A.E Levodopa Revenue Growth Rate (2016-2021) (US$ Million)
    Figure 105. Levodopa Value Chain
    Figure 106. Channels of Distribution
    Figure 107. Distributors Profiles
    Figure 108. Bottom-up and Top-down Approaches for This Report
    Figure 109. Data Triangulation
    Figure 110. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user to access the PDF.

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Leap India

RELATED REPORTS

Global Deep Brain Stimulation Devices Market Insights and Forecast to 2028
Global Deep Brain Stimulation Devices Market Insights and Forecast to 2028

While Parkinsons Disease segment is altered to an CAGR throughout this forecast period.Global Deep Brain Stimulation Devices Market Insights and Forecast to 2028.

120 Pages
Type: Report
Code: QYRE-Auto-22V9092
Fri Jan 07 00:00:00 UTC 2022

Add to Cart

Global Traumatic Brain Injury Diagnostic Market Size Status and Forecast 2022
Global Traumatic Brain Injury Diagnostic Market Size, Status and Forecast 2022

The global Traumatic Brain Injury Diagnostic market size is projected to reach US 1889.8 million by 2027 from US 838.9 million in 2020 at a CAGR of 12.7 during 20212027.Global Traumatic Brain Injury Diagnostic Market Size Status and Forecast 2022.

120 Pages
Type: Report
Code: QYRE-Auto-33S8930
Thu Jan 06 00:00:00 UTC 2022

Add to Cart

Global Neurology Software Market Size Status and Forecast 2022
Global Neurology Software Market Size, Status and Forecast 2022

The global Neurology Software market size is projected to reach US 961.2 million by 2027 from US 639.1 million in 2020 at a CAGR of 5.9 during 20212027.Global Neurology Software Market Size Status and Forecast 2022.

120 Pages
Type: Report
Code: QYRE-Auto-5H268
Thu Jan 06 00:00:00 UTC 2022

Add to Cart

Global Attention Deficit Hyperactivity Disorder ADHD Market Size Status and Forecast 2022
Global Attention Deficit Hyperactivity Disorder (ADHD) Market Size, Status and Forecast 2022

The global Attention Deficit Hyperactivity Disorder ADHD market size is projected to reach US 18060 million by 2027 from US 11480 million in 2020 at a CAGR of 6.7 during 20212027.Global Attention Deficit Hyperactivity Disorder ADHD Market Size Status and Forecast 2022.

120 Pages
Type: Report
Code: QYRE-Auto-14N9172
Thu Jan 06 00:00:00 UTC 2022

Add to Cart